Glenmark Pharmaceuticals gets FDA nod for Baddi plant in HP
Glenmark Pharmaceuticals on Monday said it has received the US Food and Drug Administration's approval for its semi solid dosage manufacturing plant at Baddi in HP.
The Baddi plant has also received GMP approval from the UK nodal agency Modern Humanities Research Association and from therapeutic products directorate, Canada. Glenmark informed the BSE.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.